🇺🇸 FDA
Pipeline program

HS-20094 Injection

HS-20094-302

Phase 3 small_molecule active

Quick answer

HS-20094 Injection for Type 2 Diabetes is a Phase 3 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).

Program details

Company
Jian Li
Indication
Type 2 Diabetes
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials